CLOV Key Statistics, Chart & Performance
The current stock price of CLOV is 2.53 USD. In the past month the price increased by 5%. In the past year, price decreased by -22.7%.
CLOV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.59 | 296.74B | ||
| ELV | ELEVANCE HEALTH INC | 11.19 | 76.29B | ||
| HUM | HUMANA INC | 13.7 | 31.18B | ||
| CNC | CENTENE CORP | 9.87 | 19.61B | ||
| MOH | MOLINA HEALTHCARE INC | 8.86 | 8.40B | ||
| HQY | HEALTHEQUITY INC | 24.65 | 7.90B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.83B | ||
| PGNY | PROGYNY INC | 40.49 | 2.20B |
Related stock screener links
About CLOV
Company Profile
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 570 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Company Info
CLOVER HEALTH INVESTMENTS CO
30 Montgomery Street
Jersey City NEW JERSEY 37067 US
CEO: Vivek Garipalli
Employees: 570
Phone: 12014322133
CLOVER HEALTH INVESTMENTS CO / CLOV FAQ
What does CLOVER HEALTH INVESTMENTS CO do?
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 570 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
What is the stock price of CLOVER HEALTH INVESTMENTS CO today?
The current stock price of CLOV is 2.53 USD. The price increased by 0.4% in the last trading session.
Does CLOV stock pay dividends?
CLOV does not pay a dividend.
What is the ChartMill rating of CLOVER HEALTH INVESTMENTS CO stock?
CLOV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is CLOVER HEALTH INVESTMENTS CO (CLOV) stock traded?
CLOV stock is listed on the Nasdaq exchange.
What sector and industry does CLOVER HEALTH INVESTMENTS CO belong to?
CLOVER HEALTH INVESTMENTS CO (CLOV) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the outstanding short interest for CLOVER HEALTH INVESTMENTS CO?
The outstanding short interest for CLOVER HEALTH INVESTMENTS CO (CLOV) is 9.97% of its float.
CLOV Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CLOV. When comparing the yearly performance of all stocks, CLOV is a bad performer in the overall market: 85.45% of all stocks are doing better.
CLOV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLOV. CLOV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CLOV Financial Highlights
Over the last trailing twelve months CLOV reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 42.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.4% | ||
| ROE | -17.08% | ||
| Debt/Equity | 0 |
CLOV Forecast & Estimates
9 analysts have analysed CLOV and the average price target is 3.3 USD. This implies a price increase of 30.35% is expected in the next year compared to the current price of 2.53.
For the next year, analysts expect an EPS growth of -96.44% and a revenue growth 25.45% for CLOV